Camber Capital Management’s Puma Biotechnology PBYI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,650,000	Closed	-$8.74M	–	40
2024 Q1	$8.74M	Sell	1,650,000 -1,155,000	-41%	-$6.22M	0.21%	34
2023 Q4	$12.1M	Sell	2,805,000 -1,430,000	-34%	-$4.74M	0.31%	32
2023 Q3	$11.1M	Hold	4,235,000	–	–	0.37%	35
2023 Q2	$14.9M	Hold	4,235,000	–	–	0.49%	32
2023 Q1	$13.1M	Hold	4,235,000	–	–	0.4%	34
2022 Q4	$17.9M	Hold	4,235,000	–	–	0.61%	30
2022 Q3	$10M	Hold	4,235,000	–	–	0.31%	45
2022 Q2	$12.1M	Buy	4,235,000 +235,000	+6%	+$584K	0.52%	32
2022 Q1	$11.5M	Buy	4,000,000 +1,950,000	+95%	+$5.04M	0.42%	32
2021 Q4	$6.23M	Sell	2,050,000 -1,375,000	-40%	-$5.97M	0.21%	34
2021 Q3	$24M	Buy	3,425,000 +700,000	+26%	+$5.24M	0.74%	33
2021 Q2	$25M	Buy	2,725,000 +170,000	+7%	+$1.72M	0.84%	34
2021 Q1	$24.8M	Hold	2,555,000	–	–	0.85%	29
2020 Q4	$26.2M	Hold	2,555,000	–	–	0.92%	29
2020 Q3	$25.8M	Buy	2,555,000 +155,000	+6%	+$1.58M	1.36%	23
2020 Q2	$25M	Buy	2,400,000 +450,000	+23%	+$4.66M	1.43%	19
2020 Q1	$16.5M	Buy	+1,950,000	New	+$18.9M	0.98%	24
2019 Q1	–	Sell	-1,300,000	Closed	-$26.5M	–	36
2018 Q4	$26.5M	Buy	1,300,000 +550,000	+73%	+$16.5M	1.26%	29
2018 Q3	$34.4M	Buy	+750,000	New	+$36.2M	1.47%	20
2017 Q2	–	Sell	-650,000	Closed	-$24.2M	–	38
2017 Q1	$24.2M	Buy	+650,000	New	+$23.7M	0.98%	25